Articles
Screener (Beta)
Semiconductor Supply Chain
ALZN Archived Articles
Alzamend Neuro (ALZN): Pioneering Novel Therapeutics for Alzheimer's, Bipolar Disorder, and More
Published on March 15, 2025
Alzamend Neuro (NASDAQ:ALZN): A Clinical-Stage Biopharmaceutical Company Driving Innovative Alzheimer’s and Mental Health Treatments
Published on November 30, 2024
Alzamend Neuro, Inc. (NASDAQ:ALZN): Promising Alzheimer's and Neuropsychiatric Therapeutics Pipeline, But Liquidity Concerns Remain
Published on September 24, 2024